ASX 200 Stocks Outlook - Investing in the right ASX stocks

Own Stocks in the ASX 200? You’re in Trouble This Decade

Today’s Profit Watch is arriving behind schedule because I spent the morning on the phone with Silicon Valley investor and futurist Tony Seba. I’m not allowed to say too much just yet. His upcoming book is still officially under ‘embargo’....
ASX MSB Share Price - Mesoblast Shares ASX

Mesoblast Ltd’s Share Price Sinks as Company Trucks Onwards

It’s been a rough day for Mesoblast Ltd . The mid-cap biotech, MSB's share price is down 2.98% at time of writing. Dragged down by a mixed day of trade for the ASX. In the grand scheme of things though, today’s...
COVID-19 Vaccine and Cure - Future of Biotech is Synbio

The Race is On to Find a COVID-19 Vaccine — How Close Are We?

There are 12 companies in the race to find a vaccine for COVID-19. And global stock markets are already bouncing back hard on the back of news that a solution is close. There’s no doubt it’ll be a great moment for...
Biotech Investment Opportunity - Synbio or Synthetic Biology

This Biotech Investment Opportunity Is More than Just Drugs

When it comes to biotechs, it’s easy to get hung up on drugs. After all, drugs are the centrepiece of healthcare. They are the medicine that cures what ails us. Or at least, that’s the intention. However, as we all know, drugs...
Synbio - The future of Biotech - Invest in Biotech

Synbio, the Paradigm Shift in Biotech: Hacking the Software of Life

Over the past couple of days, I’ve been talking about a paradigm shifting moment in biotech that’s happening right now. And how its implications on the race for a COVID-19 vaccine are just the tip of an exponential iceberg. I recorded...

Follow Us

ASX CQE Share Price - Charter Hall Social Infrastructure REIT

Charter Hall Profit up 25%, Share Price Follows Suit (ASX:CQE)

Charter Hall Social Infrastructure REIT is proving once again that it’s not all doom and gloom for property. Despite the pandemic, and the lockdown,...